Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Luckily for you, StockStory helps you navigate which companies are truly worth holding. That said, here are two low-volatility stocks that could offer consistent gains and one stuck in limbo.
One Stock to Sell:
Reynolds (REYN)
Rolling One-Year Beta: 0.22
Best known for its aluminum foil, Reynolds (NASDAQ:REYN) is a household products company whose products focus on food storage, cooking, and waste.
Why Should You Sell REYN?
- Shrinking unit sales over the past two years show it’s struggled to move its products and had to rely on price increases
- Sales are projected to be flat over the next 12 months and imply weak demand
- 4.5 percentage point decline in its free cash flow margin over the last year reflects the company’s increased investments to defend its market position
At $23.72 per share, Reynolds trades at 13.8x forward P/E. Dive into our free research report to see why there are better opportunities than REYN.
Two Stocks to Watch:
Installed Building Products (IBP)
Rolling One-Year Beta: 0.74
Founded in 1977, Installed Building Products (NYSE:IBP) is a company specializing in the installation of insulation, waterproofing, and other complementary building products for residential and commercial construction.
Why Could IBP Be a Winner?
- Annual revenue growth of 13% over the past five years was outstanding, reflecting market share gains this cycle
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 22.4% exceeded its revenue gains over the last five years
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures, and its returns are climbing as it finds even more attractive growth opportunities
Installed Building Products’s stock price of $296.60 implies a valuation ratio of 25.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Cardinal Health (CAH)
Rolling One-Year Beta: 0.44
Operating as a critical link in the healthcare supply chain since 1979, Cardinal Health (NYSE:CAH) distributes pharmaceuticals and manufactures medical products for hospitals, pharmacies, and healthcare providers across the global healthcare supply chain.
Why Does CAH Stand Out?
- Dominant market position is represented by its $234.3 billion in revenue, which creates significant barriers to entry in this highly regulated industry
- Demand will likely accelerate over the next 12 months as its forecasted revenue growth of 12.1% is above its two-year trend
- Earnings per share grew by 9.4% annually over the last five years and easily exceeded the peer group average
Cardinal Health is trading at $201.18 per share, or 20.3x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stocks We Like Even More
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.